Vaxxas_logo_bigger

Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)

Encouraging interim results from Phase 1 human clinical trial show COVID-19 vaccine candidate, called HexaPro, to be safe and well...